These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 1350925

  • 1. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
    Kovacs JA, Masur H.
    Clin Infect Dis; 1992 May; 14(5):1005-9. PubMed ID: 1350925
    [Abstract] [Full Text] [Related]

  • 2. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus.
    MMWR Recomm Rep; 1992 Apr 10; 41(RR-4):1-11. PubMed ID: 1348843
    [Abstract] [Full Text] [Related]

  • 3. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies Infectieuses.
    May T, Beuscart C, Reynes J, Marchou B, Leclercq P, Borsa Lebas F, Saba J, Micoud M, Mouton Y, Canton P.
    J Acquir Immune Defic Syndr (1988); 1994 May 10; 7(5):457-62. PubMed ID: 8158539
    [Abstract] [Full Text] [Related]

  • 4. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
    MMWR Recomm Rep; 1991 Mar 15; 40(RR-2):1-13. PubMed ID: 1672036
    [Abstract] [Full Text] [Related]

  • 5. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
    JAMA; 1991 Apr 03; 265(13):1637-40, 1643-4. PubMed ID: 1672167
    [No Abstract] [Full Text] [Related]

  • 6. From the Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with HIV.
    JAMA; 1992 May 06; 267(17):2294-6, 2298-9. PubMed ID: 1348788
    [No Abstract] [Full Text] [Related]

  • 7. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
    Carr A, Tindall B, Penny R, Cooper DA.
    AIDS; 1992 Feb 06; 6(2):165-71. PubMed ID: 1558714
    [Abstract] [Full Text] [Related]

  • 8. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
    Graham NM, Zeger SL, Park LP, Phair JP, Detels R, Vermund SH, Ho M, Saah AJ.
    Lancet; 1991 Aug 03; 338(8762):265-9. PubMed ID: 1677108
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE, Keruly J, Richman DD, Moore RD.
    Arch Intern Med; 1992 Oct 03; 152(10):2009-13. PubMed ID: 1417373
    [Abstract] [Full Text] [Related]

  • 11. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.
    Carr A, Tindall B, Brew BJ, Marriott DJ, Harkness JL, Penny R, Cooper DA.
    Ann Intern Med; 1992 Jul 15; 117(2):106-11. PubMed ID: 1351371
    [Abstract] [Full Text] [Related]

  • 12. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.
    Leoung GS, Feigal DW, Montgomery AB, Corkery K, Wardlaw L, Adams M, Busch D, Gordon S, Jacobson MA, Volberding PA.
    N Engl J Med; 1990 Sep 20; 323(12):769-75. PubMed ID: 1975426
    [Abstract] [Full Text] [Related]

  • 13. From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus.
    JAMA; 1989 Jul 21; 262(3):335-9. PubMed ID: 2525628
    [No Abstract] [Full Text] [Related]

  • 14. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus.
    Centers for Disease Control (CDC).
    MMWR Suppl; 1989 Jun 16; 38(5):1-9. PubMed ID: 2524643
    [Abstract] [Full Text] [Related]

  • 15. Prophylaxis of Pneumocystis carinii pneumonia: an update.
    Kovacs JA, Masur H.
    J Infect Dis; 1989 Nov 16; 160(5):882-6. PubMed ID: 2681438
    [Abstract] [Full Text] [Related]

  • 16. Patient tolerance of nebulized pentamidine or cotrimoxazole as secondary prophylaxis for Pneumocystis carinii pneumonia.
    Smith DE, Hills DA, Gazzard BG.
    AIDS; 1992 Sep 16; 6(9):1044-5. PubMed ID: 1388897
    [No Abstract] [Full Text] [Related]

  • 17. Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia.
    Castellano AR, Nettleman MD.
    JAMA; 1991 Aug 14; 266(6):820-4. PubMed ID: 1907671
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of aerosol pentamidine prophylaxis.
    Ong EL.
    Int J STD AIDS; 1993 Aug 14; 4(2):67-9. PubMed ID: 8476968
    [Abstract] [Full Text] [Related]

  • 20. Predicting risk of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children.
    Rutstein RM.
    Am J Dis Child; 1991 Aug 14; 145(8):922-4. PubMed ID: 1677526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.